Mablink Bioscience Enters an Agreement to be Acquired by Lilly
Mablink Bioscience appoints Pejvack Motlagh, M.D., as Chief Medical Officer
Mablink, in the supplement of the March 2023 issue of "La Jaune et la Rouge"
Mablink Bioscience to Present Promising Preclinical Data for Lead ADC Candidate MBK-103 at the AACR
A new review on the history and future of ADC payloads published by Mablink’s scientists
France 2030: Mablink is awarded 1.8 million euros in the i-Nov innovation competition
€31 million Series A funding round led by Sofinnova Partners and Mérieux Equity Partners
Mablink Bioscience announces appointment of its Head of Preclinical Research and Development